MetLife (MET) insider sell notices: 562 shares and 725 shares reported

Rhea-AI Filing Summary

MetLife reported insider sales of Common Stock. The excerpt lists dispositions of 562 shares on 01/09/2026 and 725 shares on 03/02/2026. The transactions are reported on a Form 144 covering Common Stock and reference NYSE trading.

Insights

Insider Transactions Analyst

Routine Form 144 sell notices showing small open-market dispositions.

These entries document reported dispositions of Common Stock: 562 shares on 01/09/2026 and 725 shares on 03/02/2026. The filing format and modest share counts are typical for compliance reporting of insider sales.

Cash‑flow treatment and the reporting person's identity are not shown in the excerpt; subsequent filings or the full Form 144 would give the seller identity, broker details, and whether sales were open‑market.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays 745 Seventh Ave New York NY 10019	120	8233.2	652053867	03/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/31/2014	Purchase	GOLDMAN SACHS			120	01/06/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	01/09/2026	562	44628.42
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	03/02/2026	725	53099

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider transactions does MetLife (MET) disclose on this Form 144?

The excerpt discloses dispositions of Common Stock: 562 shares on 01/09/2026 and 725 shares on 03/02/2026. These entries are recorded as Form 144 sell notices and reference NYSE trading.

Do the listed Form 144 entries identify the selling person for MET?

The provided excerpt does not show the reporting person's name. The lines list brokers and plan names but the seller identity is not included in this content; the complete Form 144 filing typically names the seller.

Were the MET shares sold through a broker or plan according to the excerpt?

The excerpt references brokers and accounts: Goldman Sachs and retirement plan entries such as a MetLife 401(k) Plan Trust. It shows method labels like Cash for a January 2015 purchase and dates for the recent dispositions.

How large are the reported MetLife insider sales relative to a typical filing threshold?

The reported amounts are 562 and 725 shares, which are modest counts for Form 144 reporting. The excerpt does not provide total holdings or percentages, so proportional impact cannot be assessed here.